{
    "Trade/Device Name(s)": [
        "Verigene Enteric Pathogens Nucleic Acid Test (EP)",
        "Verigene EP",
        "Verigene System"
    ],
    "Submitter Information": "Nanosphere, Inc.",
    "510(k) Number": "K142033",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121894",
        "K121454"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH",
        "PCI",
        "OOI"
    ],
    "Summary Letter Date": "July 24, 2014",
    "Summary Letter Received Date": "July 25, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal microorganism multiplex nucleic acid-based assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Campylobacter Group (C. coli, C. jejuni, C. lari)",
        "Salmonella species",
        "Shigella species (S. dysenteriae, S. boydii, S. sonnei, S. flexneri)",
        "Vibrio Group (V. cholerae, V. parahaemolyticus)",
        "Yersinia enterocolitica",
        "Norovirus GI/GII",
        "Rotavirus A",
        "Shiga toxin 1 gene",
        "Shiga toxin 2 gene"
    ],
    "Specimen Type(s)": [
        "Liquid stool",
        "Soft stool"
    ],
    "Specimen Container(s)": [
        "Cary-Blair medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Verigene System",
        "Verigene Reader",
        "Verigene Processor SP"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse transcription (RT)",
        "Polymerase chain reaction (PCR)",
        "Array hybridization",
        "Gold nanoparticle probe-based endpoint detection"
    ],
    "Methodologies": [
        "Multiplex nucleic acid testing",
        "RT-PCR",
        "Microarray hybridization",
        "Molecular diagnostics"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "System",
        "Platform",
        "Analyzer",
        "Cartridge",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Verigene Enteric Pathogens Nucleic Acid Test (EP), a multiplex RT-PCR and microarray assay for simultaneous detection of enteric bacteria, viruses, and genetic virulence markers from stool in Cary-Blair medium.",
    "Indications for Use Summary": "Multiplex, qualitative detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium for individuals with gastrointestinal infection symptoms; performed on Verigene System; aids diagnosis and outbreak detection.",
    "fda_folder": "Microbiology"
}